Metformin improves healthspan and lifespan in mice

[1]  R. de Cabo,et al.  Mitochondrial metabolic reprogramming induced by calorie restriction. , 2013, Antioxidants & redox signaling.

[2]  F. Berrino,et al.  Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects , 2013, Oncogene.

[3]  L. Partridge,et al.  Activation of AMPK by the Putative Dietary Restriction Mimetic Metformin Is Insufficient to Extend Lifespan in Drosophila , 2012, PloS one.

[4]  M. Redondo-Horcajo,et al.  Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial β-oxidation. , 2012, Biochimica et biophysica acta.

[5]  G. Szabo,et al.  Inflammasomes in liver diseases. , 2012, Journal of hepatology.

[6]  M. Pollak.  Investigating metformin for cancer prevention and treatment: the end of the beginning. , 2012, Cancer discovery.

[7]  E. Eldrup,et al.  [Metformin associated with lactic acidosis in treatment of type 2 diabetes]. , 2012, Ugeskrift for laeger.

[8]  Masahiro Morita,et al.  Distinct perturbation of the translatome by the antidiabetic drug metformin , 2012, Proceedings of the National Academy of Sciences.

[9]  D. Hardie,et al.  AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.

[10]  Vito Pistoia,et al.  Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.

[11]  M. Abecassis,et al.  Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation , 2012, Science Translational Medicine.

[12]  R. Reimer,et al.  Prebiotic fiber increases hepatic acetyl CoA carboxylase phosphorylation and suppresses glucose-dependent insulinotropic polypeptide secretion more effectively when used with metformin in obese rats. , 2012, The Journal of nutrition.

[13]  S. Larsen,et al.  Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration , 2012, Diabetologia.

[14]  B. Viollet,et al.  Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage , 2012, Cancer Prevention Research.

[15]  Z. Darżynkiewicz,et al.  Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling , 2011, Aging.

[16]  I. Ben-Sahra,et al.  Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. , 2011, Cancer research.

[17]  R. de Cabo,et al.  Negative Regulation of STAT3 Protein-mediated Cellular Respiration by SIRT1 Protein* , 2011, The Journal of Biological Chemistry.

[18]  P. Navas,et al.  NRF2, cancer and calorie restriction , 2011, Oncogene.

[19]  V. Anisimov,et al.  If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice , 2011, Aging.

[20]  V. Anisimov,et al.  Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice , 2010, Aging.

[21]  Ya-xiong Shi.  Diabetes and Cancer: A Consensus Report , 2010 .

[22]  P. Neufer,et al.  Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. , 2010, Free radical biology & medicine.

[23]  U. Smith,et al.  AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3) , 2010, Diabetologia.

[24]  D. Yee,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[25]  X. Hou,et al.  Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. , 2010, Biochemical and biophysical research communications.

[26]  D. Allison,et al.  Metformin supplementation and life span in Fischer-344 rats. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  Allan R Brasier,et al.  The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. , 2010, Cardiovascular research.

[28]  M. Driscoll,et al.  Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1 , 2010, PloS one.

[29]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[30]  P. Donnan,et al.  New Users of Metformin Are at Low Risk of Incident Cancer , 2009, Diabetes Care.

[31]  F. Wondisford,et al.  Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein , 2009, Cell.

[32]  G. Prasad,et al.  Oxidative stress mediated cytotoxicity of cyanide in LLC-MK2 cells and its attenuation by alpha-ketoglutarate and N-acetyl cysteine. , 2009, Toxicology letters.

[33]  S. Correia,et al.  Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview. , 2008, Mini reviews in medicinal chemistry.

[34]  J. Dyck,et al.  Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms. , 2008, American journal of physiology. Heart and circulatory physiology.

[35]  J. Schwartz,et al.  Radiation cataracts: mechanisms involved in their long delayed occurrence but then rapid progression , 2008, Molecular vision.

[36]  In-kyu Lee,et al.  Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP , 2008, Diabetes.

[37]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[38]  G. Lopaschuk,et al.  Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. , 2006, American journal of physiology. Endocrinology and metabolism.

[39]  S. Spindler.  Use of microarray biomarkers to identify longevity therapeutics , 2006, Aging cell.

[40]  G. Fahy,et al.  Identification of potential caloric restriction mimetics by microarray profiling. , 2005, Physiological genomics.

[41]  G. Wilcox.  Insulin and insulin resistance. , 2005, The Clinical biochemist. Reviews.

[42]  Claudia M Testa,et al.  Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. , 2005, Brain research. Molecular brain research.

[43]  G. López-Lluch,et al.  Demethoxy-Q, An Intermediate of Coenzyme Q Biosynthesis, Fails to Support Respiration in Saccharomyces cerevisiae and Lacks Antioxidant Activity* , 2004, Journal of Biological Chemistry.

[44]  M. Roden,et al.  Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? , 2004, Diabetes.

[45]  J. Yudkin,et al.  Metformin and its liver targets in the treatment of type 2 diabetes. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.

[46]  K. Becker,et al.  Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.

[47]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[48]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[49]  Sydney Brenner,et al.  The End of the Beginning , 2000, Science.

[50]  M. Rigoulet,et al.  Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.

[51]  J. Levy,et al.  Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program , 1998, Diabetes Care.

[52]  A. Turturro,et al.  Age-Related Neoplasia in a Lifetime Study of Ad Libitum-Fed and Food-Restricted B6C3F1 Mice , 1995, Toxicologic pathology.

[53]  C. Catalano,et al.  The Effect of Intravenous Metformin on Glucose Metabolism During Hyperglycaemia in Type 2 Diabetes , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[54]  S. Segawa,et al.  End of the beginning , 1990, Nature.

[55]  I A Mjör,et al.  Consensus Report , 1985, Journal of dental research.

[56]  H. Green,et al.  QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES , 1963, The Journal of cell biology.

[57]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[58]  A. Lafuente,et al.  [Metformin-associated lactic acidosis: incidence, diagnosis, prognostic factors and treatment]. , 2012, Revista espanola de anestesiologia y reanimacion.

[59]  L. Peshkin,et al.  Supplemental Data Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span , 2008 .

[60]  D. Volsky,et al.  BMC Bioinformatics Methodology article PAGE: Parametric Analysis of Gene Set Enrichment , 2004 .

[61]  Rajakrishnan Rajkumar,et al.  Grammar Engineering for CCG using Ant and XSLT ∗ , 2001 .

[62]  L. Ferrucci,et al.  American Journal of Epidemiology Original Contribution Changes in Weight at the End of Life: Characterizing Weight Loss by Time to Death in a Cohort Study of Older Men , 2022 .